BLOOD PRODUCTS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Global Blood Products Market Size and Forecast – 2025 to 2032

The Global Blood Products Market is estimated to be valued at USD 38.20 Bn in 2025 and is expected to reach USD 52.69 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.7% from 2025 to 2032.

Key Takeaways of the Global Blood Products Market:

• In the product category segment, whole blood is expected to hold the largest market share at 39.2% in 2025.
• In the application segment, hematology leads the market with an estimated share of 28.3% in 2025.
• Among the various technologies in the global blood products market, automated blood collection systems dominate with an estimated market share of 32.1% in 2025.
• North America is expected to lead the market, holding a share of 44.3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 25.2% in 2025.

Market Overview:

The blood products market is experiencing significant growth due to several factors. Firstly, the increasing prevalence of chronic diseases and rising demand for blood transfusions are driving the market growth. Secondly, advancements in blood collection, processing, and storage technologies are enhancing the safety and efficiency of blood products. Additionally, the growing geriatric population and increasing number of surgical procedures are further fueling the demand for blood products. However, the market growth may be hindered by the high costs associated with blood collection and processing, as well as the risk of transfusion-transmitted infections.

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Analysis

To learn more about this report, Request sample copy

Blood Products Market Insights, By Product Category - Whole blood leads the market due to its lifesaving properties and versatile applications

In terms of product category, the whole blood segment is expected to contribute the highest share of the market with 39.2% in 2025 owing to its lifesaving properties and versatile applications in various medical procedures. Whole blood, which contains all the essential components such as red blood cells, white blood cells, platelets, and plasma, plays a crucial role in maintaining the body's normal functioning and treating a wide range of health conditions.

A key factor propelling the growth of the whole blood segment is its vital importance in emergency medical scenarios, such as traumatic injuries or major surgeries. In these critical situations, the prompt transfusion of whole blood is often lifesaving, as it quickly replenishes lost blood volume and restores the body's oxygen-carrying capacity.

For instance, in March 2025, EMS, an emergency medical service provider in the U.S , became the first in Kentucky ,U.S. to offer on-site whole-blood transfusions. Announced by Mayor Mr. Craig Greenberg, the initiative aims to improve trauma care across the city, which handles around 120,000 emergency calls annually. In partnership with the American Red Cross, the program will begin with two vehicles equipped to carry and administer warmed blood at the scene.

Blood Products Market Insights, By Technology – Automated blood collection systems dominate the market due to their ability to improve efficiency, reduce human error, and enhance safety

Among the various technologies in the global blood products market, automated blood collection systems is the dominant segment with a share of 32.1% in 2025. This technology is rapidly gaining traction due to its significant advantages in improving the efficiency, safety, and accuracy of blood collection. Automated systems reduce human error, enhance operational efficiency, and ensure precise separation of blood components, leading to optimized yields and reduced wastage. Additionally, automation helps in streamlining blood collection processes, reducing time and resource costs, and improving patient and donor experiences.

The increasing demand for blood components, coupled with the need for high precision and reduced risk of contamination, makes automated systems a critical technology. These systems also align with the growing emphasis on safety, as they minimize the risk of transfusion-related infections, a crucial factor in improving patient outcomes.

For instance, in September 2024, Kriya Medical Technologies, based in Chennai, India, launched the ICHOR Medical Molding System on September 18, 2024, with a production capacity of 250 million blood collection tubes annually. This fully automated system aims to position India as a key player in global medical device manufacturing, with plans to export to markets like the U.S., Canada, and Japan.

Regional Insights

To learn more about this report, Request sample copy

North America Blood Products Market Analysis and Trends

North America’s dominance in the global blood products market with an estimated share of 44.3% in 2025 can be attributed to several key factors. The region boasts a well-established healthcare infrastructure, coupled with a high adoption rate of advanced medical technologies. The presence of major pharmaceutical and biotech companies, such as Baxter International, CSL Behring, and Grifols, has significantly contributed to the market's growth.

These companies have invested heavily in research and development, leading to the introduction of innovative blood products. Moreover, favorable government policies, including funding for blood-related research and development, have further propelled the market's expansion. The region's large patient population, coupled with increasing awareness about the importance of blood donations, has also played a crucial role in maintaining its dominant position.

Asia Pacific Blood Products Market Analysis and Trends

The Asia Pacific region is expected to exhibit the fastest growth in the global blood products market with a share of 25.2% in 2025. This growth can be ascribed to the rapidly developing healthcare infrastructure, increasing government initiatives to promote blood donation, and rising awareness about the importance of safe blood transfusions devices. Countries like China and India, with their large populations and growing healthcare expenditure, have emerged as significant contributors to the market's growth. The increasing prevalence of chronic diseases and the rising number of surgical procedures have further fueled the demand for blood products in the region.

For instance, in October 2024, the Rotary Bangalore TTK Blood Centre’s Bangalore Medical Services Trust (BMST), in collaboration with the Karnataka, India State Blood Transfusion Council, launched Karnataka’s first 'Rare Blood Donor' programme. Introduced by Health Minister Dinesh Gundu Rao on National Voluntary Blood Donation Day, the initiative aims to build a registry of rare blood group donors and a repository of frozen red cell units to support patients with uncommon blood types.

Global Blood Products Market Outlook for Key Countries

U.S. Blood Products Market Trends

The U.S. market for blood products is highly advanced, with a strong emphasis on safety and quality. The country's stringent regulatory framework, overseen by the U.S Food and Drug Administration (FDA), ensures the production and distribution of high-quality blood products. Major players like the American Red Cross and America's Blood Centers play a vital role in collecting, processing, and distributing blood products across the country. The market is also driven by the increasing prevalence of chronic diseases, an aging population, and advancements in surgical procedures.

For instance, in March 2025, Novant Health, part of the Novant Health network, launched its Pre-Hospital Blood Program in North Carolina, U.S. becoming one of only 200 EMS agencies in the U.S. to administer blood transfusions in the field. Four specially equipped vehicles across New Hanover County carry blood coolers with red blood cells, plasma, and warming equipment to deliver life-saving care before hospital arrival, significantly reducing treatment delays.

U.K. Blood Products Market Trends

The U.K. blood products market is experiencing significant growth, driven by technological advancements and increasing demand. Key trends include innovations in blood collection, testing, and plasma fractionation, with a focus on improving efficiency and safety. Automation in blood grouping and the development of synthetic blood products are also gaining traction, aiming to address blood shortages and enhance trauma care.

For instance, in May 2024, Health Minister Mr. Robin Swann launched the U.K. and Europe’s first regional Blood Production and Tracking (BPaT) system at the Northern Ireland Blood Transfusion Service (NIBTS). This new digital solution enables complete traceability of blood from donor to recipient, aiming to improve safety and quality. NIBTS plays a vital role in supplying blood for around 500 patients weekly in Northern Ireland.

Japan Blood Products Market Trends

Japan's market for blood products is characterized by its focus on safety, quality, and self-sufficiency. The country has a well-organized blood donation system, with the Japanese Red Cross Society playing a central role in collecting and distributing blood products. The government has implemented policies to encourage voluntary blood donations and maintain a stable supply of blood products. Local companies, such as the Japan Blood Products Organization and Benesis Corporation, have a strong presence in the market, focusing on the development of advanced blood products and technologies.

For instance, in January 2025, Korea Ginseng Corporation (KGC), a leading health supplement manufacturer, expanded its blood sugar management range following approval from the Korea Food and Drug Administration (KFDA). Under its JungKwanJang brand, KGC launched two new products—GLPro Core and GLPro Doublecut—targeted at blood sugar control, with the latter also supporting body fat reduction.

India Blood Products Market Trends

India's market for blood products is rapidly evolving, driven by the increasing demand for safe blood transfusions, rising healthcare expenditure, and government initiatives to improve the blood donation infrastructure. The country faces challenges in terms of ensuring an adequate and safe blood supply, given its large population and diverse geographic landscape. However, the government has taken steps to strengthen the blood banking system, including the establishment of national and state-level blood transfusion councils.

For instance, in June 2021, Biolog-id, a global provider of connected healthcare solutions, opened a regional office in New Delhi to strengthen its presence in India. Known for its advanced blood component tracking systems, Biolog-id aims to meet the country's growing demand for improved blood product management, cost control, and transfusion safety.

China Blood Products Market Trends

China's market for blood products has witnessed significant growth in recent years, driven by the country's large population, increasing healthcare expenditure, and government initiatives to improve the blood donation system. The Chinese government has implemented various policies to ensure the safety and adequacy of the blood supply, including the establishment of a nationwide blood management network. Local companies, such as Shanghai RAAS Blood Products and Sichuan Yuanda Shuyang Pharmaceutical, have emerged as key players in the market, focusing on research and development to introduce innovative products.

End User Feedback and Unmet Needs – Blood Products Market

• Healthcare providers, including hospitals and labs, have praised advancements like lyophilized coagulation factors for their stability and ease of use, especially in emergency care. These innovations have improved patient outcomes and operational efficiency. However, challenges such as inconsistent supply, high costs, and limited access—particularly in low-resource regions—remain significant. For example, public health systems in parts of Africa report frequent shortages of immunoglobulins during disease outbreaks, highlighting supply chain vulnerabilities.
• Key unmet needs include better integration with digital systems, more customised products for diverse patient groups, and improved affordability. Smaller facilities often lack infrastructure for storage and proper handling. Addressing these gaps through regional production, smart packaging, and flexible dosing could enhance accessibility, drive innovation, and strengthen market resilience, benefiting both providers and patients.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Request sample copy

Key Developments:

• In March 2025, Novant Health, part of the Novant Health network, launched its Pre-Hospital Blood Program in Wilmington, NC, becoming one of only 200 EMS agencies in the U.S. to administer blood transfusions in the field. Four specially equipped vehicles across New Hanover County carry blood coolers with red blood cells, plasma, and warming equipment to deliver life-saving care before hospital arrival, significantly reducing treatment delays.
• In February 2025, Dallas Fire-Rescue, the city’s emergency response agency, is launching a pilot program to provide pre-hospital blood transfusions for trauma patients. In partnership with Parkland Health and the American Red Cross, the initiative will equip two ambulances to deliver life-saving transfusions at the scene of critical injuries. The program, overseen by the city’s Office of the Medical Director, is set to begin later this month.
• In October 2024, Terumo Blood and Cell Technologies, a global leader in blood and cell therapy solutions, introduced its Reveos Automated Blood Processing System in the U.S. Already used in 50+ countries, Reveos streamlines whole blood processing to enhance efficiency and component yield. Carter BloodCare in Texas, U.S. will be among the first to implement the system for producing platelets, RBCs, and plasma.
• In April 2024, BD (Becton, Dickinson and Company), a global leader in medical technology, launched the BD Vacutainer UltraTouch Push Button Blood Collection Set in India. Designed with BD RightGauge and PentaPoint technologies, the device uses a thinner needle to significantly reduce insertion pain while ensuring single-prick success. The push-button mechanism also lowers the risk of needlestick injuries by 88%.

Top Strategies Followed by Global Blood Products Market Players

• Established players in the global blood products market are focusing on extensive research and development to innovate high-performance products. These companies are investing heavily in R&D to develop advanced blood products that offer superior efficacy and safety. For instance, leading companies are working on developing novel blood-derived therapies, such as plasma-derived products and recombinant factors, to address unmet medical needs. Moreover, these companies are also forming strategic partnerships with major industry players or original equipment manufacturers (OEMs) to solidify their market presence.
  • For instance, in November 2024, QPS Holdings, LLC, a full-service CRO supporting drug development, launched a new Cell Therapy unit at its QPS Missouri campus. The unit’s first milestone is the opening of a Leukopak collection and blood product processing center to meet rising demand in cell and gene therapy. The facility will soon support clinical and commercial therapy needs while contributing to the local economy through donor stipends.

• Mid-level players in the market are adopting strategies focused on delivering quality, budget-friendly products targeting price-sensitive consumers. These companies are leveraging cost-effective manufacturing processes and optimizing their supply chains to offer competitive pricing. Additionally, they are collaborating with other players to boost their technology, production capabilities, and market presence. These collaborations help mid-level players to access new markets, share expertise, and jointly develop innovative blood products.
  • For instance, in February 2025, Cobb County Fire & Emergency Services, in collaboration with LifeSouth Community Blood Centers, launched a pre-hospital blood transfusion program on Valentine’s Day. Select units began carrying packed red blood cells and plasma to provide life-saving care at trauma scenes, aiming to improve survival rates through faster intervention for critically injured patients.

• Small-scale players in the global blood products market are targeting niche markets with unique features or innovative products. These companies are focusing on developing specialized blood products that cater to specific patient populations or rare diseases. Small-scale players are also forming local alliances with startups or local manufacturers to gain market entry and visibility.
  • For Example, Kedrion Biopharma, biopharmaceutical company that, operates with a focused approach in niche blood plasma product markets. Kedrion has developed specialised plasma-derived therapies for rare conditions such as congenital fibrinogen deficiency and Rhesus (Rh) Incompatibility.

Market Report Scope

Blood Products Market Dynamics

To learn more about this report, Request sample copy

Blood Products Market Driver - Increasing Prevalence of Blood Disorders

The rising prevalence of various blood disorders worldwide is a significant driver for the growth of the global blood products market. Conditions such as anemia, hemophilia, leukemia, and thrombocytopenia are becoming more common, leading to an increased demand for blood products. Factors contributing to this trend include an aging population, unhealthy lifestyles, and genetic predisposition. As the incidence of these disorders continues to grow, the need for blood products, such as red blood cells, platelets, and plasma-derived products, is expected to rise accordingly. Moreover, advancements in diagnostic technologies have improved the detection and diagnosis of blood disorders, further fueling the demand for blood products.

The growing awareness about these conditions and the availability of effective treatments are also encouraging patients to seek medical attention, thereby driving the market growth. For instance, on May 22, 2025, India is facing a hidden health crisis, with over 28.4% of 20,000 children tested positive for inherited blood disorders, according to a recent study by Metropolis Healthcare. The research indicates that over 25% of children under the age of 12 are affected by genetic blood disorders such as thalassaemia and sickle cell disease, with nearly half of these cases occurring in children younger than three years old. The findings underscore the urgent need for early screening and region-specific health policies to address this growing issue.

Blood Products Market Opportunity - Advancements in Blood Product Technologies

The global blood products market is witnessing a significant opportunity in the form of advancements in blood product technologies. Researchers and manufacturers are continually developing innovative solutions to enhance the safety, efficacy, and shelf life of blood products. For instance, pathogen reduction technologies are being employed to minimize the risk of transfusion-transmitted infections, providing an additional layer of safety to blood products. Moreover, the development of extended shelf-life platelets and red blood cells is reducing wastage and improving the availability of these critical components. Advancements in blood component separation techniques, such as apheresis, are enabling the efficient collection of specific blood components, leading to increased productivity and cost-effectiveness.

Furthermore, the integration of automation and data management systems in blood banks is streamlining processes, reducing human error, and improving overall operational efficiency. These technological advancements present a significant opportunity for market players to develop innovative products, expand their product portfolios, and cater to the evolving needs of healthcare providers and patients worldwide. For example, Haemonetics Corporation has developed automated blood component separation systems that streamline blood collection and transfusion, enabling faster, more efficient, and targeted component extraction in clinical settings.

Analyst Opinion (Expert Opinion)

• The global blood products market is experiencing significant growth, driven by technological advancements in blood product technologies, regulatory support, and rising demand for safe and effective transfusion solutions. Key driving factors include innovations such as pathogen reduction technologies, which enhance transfusion safety, and the development of extended shelf-life platelets and red blood cells, reducing wastage and improving availability. Additionally, the integration of automation and data management systems in blood banks is improving operational efficiency and reducing human error. Emerging opportunities lie in the growing demand for specialized blood components, along with advancements in blood component separation techniques, providing a more cost-effective and productive approach to blood collection.
• Notable challenges include the increasing complexity of regulatory compliance, as governments implement stricter safety standards. Industry conferences like the World Congress of the International Society of Blood Transfusion (ISBT) and the European Blood and Marrow Transplantation (EBMT) annual meetings have been crucial in fostering collaboration and knowledge exchange. Real-world initiatives such as Grifols' pathogen reduction technology and Haemonetics' automation systems highlight industry innovation. Furthermore, regional programs like India's National Blood Transfusion Council are working to enhance blood product safety and availability, contributing to a more robust global market outlook.

Market Segmentation

•  Product Category Insights (Revenue, USD Bn, 2020 - 2032)
• • Whole Blood
  • Blood Components
    • Red Blood Cells (RBCs)
    • Platelets
    • Plasma
    • White Blood Cells (WBCs)
    • Cryoprecipitate
  • Plasma-derived Products
    • Immunoglobulins
    • Albumin
    • Coagulation Factors
    • Hyperimmune Globulins
    • Others
•  Application Insights (Revenue, USD Bn, 2020 - 2032)
• • Hematology
  • Immunology
  • Neurology
  • Oncology
  • Hematology
  • Others
•  Technology Insights (Revenue, USD Bn, 2020 - 2032)
• • Manual Blood Collection and Processing
  • Automated Blood Collection Systems
  • Blood Fractionation and Plasma Separation
  • Pathogen Reduction Technologies
  • Precision Blood Typing and Grouping Systems
  • Others
•  Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
• • Pediatric Patients
  • Adult Patients
  • Geriatric Patients
•  End User Insights (Revenue, USD Bn, 2020 - 2032)
• • Hospitals
  • Blood Banks
  • Ambulatory Surgical Centers
  • Transfusion Centers
  • Diagnostic Laboratories
  • Research Institutions
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
• • Grifols
  • CSL Behring
  • Fresenius Kabi
  • Octapharma
  • Takeda Pharmaceutical Company
  • Sanofi
  • Kedrion Biopharma
  • Biotest AG
  • Mitsubishi Tanabe Pharma Corporation
  • HemaCare
  • BloodCenter of Wisconsin
  • Terumo BCT
  • Prothera Biosciences
  • American Red Cross
  • Vitalant

Sources

Primary Research Interviews:

• Health care providers (e.g., hospitals, blood banks, healthcare professionals)
• Industry experts (e.g., medical device manufacturers, blood collection technology experts)
• Regulatory bodies (e.g., USFDA officials, EMA representatives)
• Blood product distributors and logistics experts
• Blood donation organizations (e.g., American Red Cross, NHS Blood and Transplant)

Databases:

• World Health Organization (WHO) - Global Health Observatory
• U.S. Centers for Disease Control and Prevention (CDC)
• European Medicines Agency (EMA)
• National Institutes of Health (NIH)
• U.S. Food and Drug Administration (FDA)
• Health Canada (for Canadian blood product regulations)
• National Blood Authority (UK) - Data on blood collection and distribution

Magazines:

• Transfusion Medicine Reviews - Journal that includes global transfusion trends and practices
• Blood Transfusion - Journal focusing on blood product use, clinical practices, and research
• Journal of Clinical Apheresis - Dedicated to blood collection and separation technologies
• The Journal of Blood Medicine - Research on blood disorders and the clinical use of blood products

Journals:

• The Lancet Hematology - Leading research journal in hematology
• British Journal of Haematology - Peer-reviewed journal focusing on blood diseases and therapies
• Haematologica - Journal of the European Hematology Association
• Journal of Blood Disorders & Transfusion - Scholarly articles on clinical transfusion and blood disorders
• American Journal of Hematology - In-depth articles on hematology research and clinical applications

Newspapers:

• The New York Times - Health section often covers blood products, transfusion safety, and innovations
• The Guardian - Reporting on health and medical issues, including blood products and transfusions
• The Washington Post - Health coverage with occasional focus on blood donation and transfusion policies
• The Wall Street Journal - Business and healthcare sections that sometimes cover developments in the blood products industry
• Reuters Health - Global health news with frequent reports on blood products and public health initiatives

Associations:

• American Association of Blood Banks (AABB) - Provides extensive research, guidelines, and data on blood products
• International Federation of Red Cross and Red Crescent Societies (IFRC) - Global perspective on blood donation and distribution
• International Society of Blood Transfusion (ISBT) - Publishes reports on blood collection, transfusion, and safety standards
• World Health Organization (WHO) Blood Transfusion Service

Public Domain Sources:

• Google Scholar
• U.S. National Library of Medicine (NLM)
• OpenAIRE
• Cochrane Library

Proprietary Elements:

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years